Theravance Biopharma (TBPH) PT Lowered to $10 at BofA Securities
Tweet
Share
E-mailGet Alerts TBPH Hot Sheet
Price: $16.97 --0%
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 17
Rating Summary:
4 Buy, 10 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 11 | New: 17
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Theravance Biopharma (NASDAQ: TBPH) to $10.00 (from $11.00) while maintaining a Underperform rating.
You May Also Be Interested In
- Gemini Space Station (GEMI) PT Lowered to $7 at Mizuho
- Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $30 at Mizuho
- Cochin Shipyard Ltd (COCHIN:IN) PT Raised to INR860 at Kotak
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
